Baxter’s sales reached $2.6 billion in the second quarter, marking a 4 percent increase year over year.
U.S. sales showed a 10 percent increase, hitting $1.1 billion, while international sales reached 1.5 billion, representing a 1 percent increase from the second quarter of 2015.
The company’s sales of hospital products marked a 6 percent increase to reach $1.6 billion, while renal sales hit $965 million, showing a 2 percent increase.
After a strong financial performance for the first six months of the year, Baxter is updating is financial outlook for 2016, expecting higher total sales growth and earnings.
More articles on supply chain:
The shortage continues: Red Cross desperate for blood donations
Patients in Texas and Florida gain easier access to opioid-overdose antidote naloxone
Pills laced with fentanyl invade drug market
